Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Blood (2019) 134 (Supplement_1): 1540.

https://doi.org/10.1182/blood-2019-131367

Published: 2019

Journal Articles

Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality

Chloe Stiggelbout, Megan Real-Hall, Innocent Mutyaba, MBChB, MS, Elizabeth M Krantz, Scott Adams, PhD, Thomas S. Uldrick, MD MS, Jackson Orem, MBChB, MMed, PhD, Corey Casper, MD MPH, Suzanne McGoldrick, MD MPH, Steven Kussick, MD

Blood (2018) 132 (Supplement 1): 2271.

https://doi.org/10.1182/blood-2018-99-116263

Published: 2018

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

Blood (2017) 130 (Supplement 1): 39.

https://doi.org/10.1182/blood.V130.Suppl_1.39.39

Published: 2017

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

Daniela S Gerhard, PhD, Bruno Grande, B. Sc., Nicholas Griner, PhD, Corey Casper, MD, Sarah E. Gerdts, MPH, Abraham Omoding, MD, Jackson Orem, MD, Sam M Mbulaiteye, MD, Martin D. Ogwang, MD, Steven J. Reynolds, MD MPH, Kishor Bhatia, PhD, Leona Ayers, MD, John K Choi, MD, Charles G. Mullighan, MBBS, MSc, PhD, John T. Sandlund, MD, Thomas B. Alexander, MD MPH, Jeremy S. Abramson, MD, Thomas G. Gross, MD PhD, Ariela Noy, MD PhD, Jeffrey Bethony, PhD, Fabio Leal, MD, PhD, Timothy C Greiner, MS, MD, Elaine S. Jaffe, MD, Nancy Lee Harris, MD, Julie M. Gastier-Foster, PhD, Jay Bowen, MS, Benjamin Hanf, Roland Schmitz, PhD, Jean-Paul Martin, MD, Marie-Reine Martin, MD, John D. Irvin, MD PhD, Ellen Miller, MS, Patee Gesuwan, Leandro C. Hermida, Tanja M. Davidsen, PhD, Andrew J. Mungall, Yussanne Ma, PhD, Marco A. Marra, PhD, Ryan D. Morin, Louis M. Staudt, MD PhD

Blood (2016) 128 (22): 1760.

https://doi.org/10.1182/blood.V128.22.1760.1760

Published: 2016

Journal Articles

Impact of a Quality Improvement Project on Pediatric Endemic Burkitt Lymphoma Outcomes in Uganda

Suzanne M McGoldrick, MD MPH, Abrahams Omoding, MB ChB, MMed, Sarah E. Gerdts, MPH, Innocent Mutyaba, MB ChB, MMED, Elizabeth Krantz, B.A., M.S., Jackson Orem, MD, Corey Casper, MD

Blood (2016) 128 (22): 156.

https://doi.org/10.1182/blood.V128.22.156.156

Published: 2016

Journal Articles

Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing

David G. Coffey, MD, Katharine A. Lombardo, BS, Andrea M. H. Towlerton, BS, Sarah E. Gerdts, MPH, Corey Casper, MD, Jackson Orem, MD, Edus H. Warren, III, MD PhD

Blood (2015) 126 (23): 3896.

https://doi.org/10.1182/blood.V126.23.3896.3896

Published: 2015

Journal Articles

Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma

Katharine Lombardo, Andrea M. H. Towlerton, Alicia Morales, Sarah Gerdts, MPH, Innocent Mutyaba, MD, Abrahams Omoding, MD, Jackson Orem, MD, Erica Sessle, MPH, Corey Casper, MD, Edus Warren, MD PhD

Blood (2014) 124 (21): 1687.

https://doi.org/10.1182/blood.V124.21.1687.1687

Published: 2014

Journal Articles

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Frits van Rhee, MD PhD, Corey Casper, MD, Margaret K Vernon, PhD, Dylan Trundell, MSc, Don Robinson, MSPH, Jianming He, PhD, Jessica Vermeulen, MD PhD, Helgi van de Velde, MD PhD, Raymond S Wong, MD

Blood (2014) 124 (21): 4469.

https://doi.org/10.1182/blood.V124.21.4469.4469

Published: 2014

Journal Articles

Long-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease,

Razelle Kurzrock, MD, Peter M. Voorhees, MD, Corey Casper, MD, Richard R. Furman, MD, Luis Fayad, MD, Sagar Lonial, MD, Hossein Borghaei, DO, Sundar Jagannath, MD, Lubomir Sokol, MD, PhD, Saad Usmani, MD, FACP, Helgi van de Velde, MD, PhD, Xiang Qin, PhD, Ming Qi, MD, PhD, Mark J. Cornfeld, MD, MPH, Frits van Rhee, MD, PhD

Blood (2011) 118 (21): 3959.

https://doi.org/10.1182/blood.V118.21.3959.3959

Published: 2011

NARROW

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

Impact of a Quality Improvement Project on Pediatric Endemic Burkitt Lymphoma Outcomes in Uganda

Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing

Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Long-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only